certolizumab pegol [Certolizumab Pegol]

tematický
47
Termíny

certolizumab pegovaný
Cimzia
kertolizumab pegol

 

CDP 870
CDP870
Cimzia

Perzistentní odkaz   https://www.medvik.cz/link/D000068582
Definice

A polyethylene-glycolated Fab' fragment of TUMOR NECROSIS FACTOR antibody that binds specifically to TNF-ALPHA and neutralises it in a dose-dependent manner. It also inhibits the production of lipopolysaccharide-induced TNF-ALPHA and IL-1 BETA and is used to treat RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS.

DUI
D000068582 MeSH Prohlížeč
CUI
M0507051
Historická pozn.
2016 (2003)
Veřejná pozn.
2016; CERTILIZUMAB PEGOL was indexed under IMMUNOGLOBULIN FAB FRAGMENTS 2003-2015, POLYETHYLENE GLYCOLS 2003-2015, and under ANTIBODIES, MONOCLONAL, HUMANIZED 2003-2015

Povolená podhesla

AN
analýza
AD
aplikace a dávkování 12
BI
biosyntéza
CH
chemie
HI
dějiny
EC
ekonomika 1
PK
farmakokinetika 1
PD
farmakologie 10
PH
fyziologie
GE
genetika
IM
imunologie
IP
izolace a purifikace
CL
klasifikace
BL
krev
ME
metabolismus 1
UR
moč
CF
mozkomíšní mok
PO
otrava
AE
škodlivé účinky 5
TU
terapeutické užití 20
TO
toxicita
DE
účinky léků
RE
účinky záření
UL
ultrastruktura

D Chemikálie a léčiva
D05 makromolekulární látky 103
D05.750 polymery 1 054
D05.750.741 polyethylenglykoly 397
D05.750.741.125 certolizumab pegol 47
D05.750.741.250 cetomakrogol 2
D05.750.741.485 PEG-DMA hydrogel 25
D05.750.741.575 nonoxynol 4
D05.750.741.610 oktoxynol 8
D05.750.741.630 polidokanol 3
D05.750.741.650 poloxalen
D05.750.741.667 poloxamer 14
D05.750.741.685 polyhydroxyethylmethakrylát 45
D05.750.741.700 polysorbáty 32
D12 aminokyseliny, peptidy a proteiny 16
D12.644 peptidy 1 382
D12.644.541 peptidové fragmenty 358
D12.644.541.500 imunoglobuliny - fragmenty 187
D12.644.541.500.650 imunoglobuliny - Fab fragmenty 65
D12.644.541.500.650.125 abciximab 14
D12.644.541.500.650.250 certolizumab pegol 47
D12.644.541.500.650.500 variabilní oblast imunoglobulinu 36
D12.644.541.500.650.750 tuftsin 5
D12.776 proteiny 2 577
D12.776.124 krevní proteiny 909
D12.776.124.486 imunoproteiny 14
D12.776.124.486.485 imunoglobuliny 1 489
D12.776.124.486.485.114 protilátky 1 815
D12.776.124.486.485.114.224 monoklonální protilátky 4 629
D12.776.124.486.485.114.224.060 humanizované monoklonální protilátky 2 790
D12.776.124.486.485.114.224.060.125 abciximab 14
D12.776.124.486.485.114.224.060.250 adalimumab 347
D12.776.124.486.485.114.224.060.313 alemtuzumab 123
D12.776.124.486.485.114.224.060.344 basiliximab 2
D12.776.124.486.485.114.224.060.375 bevacizumab 445
D12.776.124.486.485.114.224.060.438 brentuximab vedotin 40
D12.776.124.486.485.114.224.060.500 certolizumab pegol 47
D12.776.124.486.485.114.224.060.750 cetuximab 185
D12.776.124.486.485.114.224.060.766 daklizumab 6
D12.776.124.486.485.114.224.060.782 denosumab 150
D12.776.124.486.485.114.224.060.790 gemtuzumab 16
D12.776.124.486.485.114.224.060.794 inotuzumab ozogamicin 12
D12.776.124.486.485.114.224.060.798 ipilimumab 253
D12.776.124.486.485.114.224.060.813 natalizumab 156
D12.776.124.486.485.114.224.060.829 nivolumab 432
D12.776.124.486.485.114.224.060.844 omalizumab 112
D12.776.124.486.485.114.224.060.860 palivizumab 12
D12.776.124.486.485.114.224.060.864 panitumumab 57
D12.776.124.486.485.114.224.060.866 ramucirumab 1
D12.776.124.486.485.114.224.060.868 ranibizumab 61
D12.776.124.486.485.114.224.060.875 trastuzumab 269
D12.776.124.486.485.114.224.060.937 ustekinumab 121
D12.776.124.486.485.680 imunoglobuliny - fragmenty 187
D12.776.124.486.485.680.650 imunoglobuliny - Fab fragmenty 65
D12.776.124.486.485.680.650.125 abciximab 14
D12.776.124.486.485.680.650.250 certolizumab pegol 47
D12.776.124.486.485.680.650.500 variabilní oblast imunoglobulinu 36
D12.776.124.486.485.680.650.750 tuftsin 5
D12.776.124.790 sérové globuliny 61
D12.776.124.790.651 imunoglobuliny 1 489
D12.776.124.790.651.114 protilátky 1 815
D12.776.124.790.651.114.224 monoklonální protilátky 4 629
D12.776.124.790.651.114.224.060 humanizované monoklonální protilátky 2 790
D12.776.124.790.651.114.224.060.125 abciximab 14
D12.776.124.790.651.114.224.060.250 adalimumab 347
D12.776.124.790.651.114.224.060.375 alemtuzumab 123
D12.776.124.790.651.114.224.060.407 basiliximab 2
D12.776.124.790.651.114.224.060.438 bevacizumab 445
D12.776.124.790.651.114.224.060.469 brentuximab vedotin 40
D12.776.124.790.651.114.224.060.500 certolizumab pegol 47
D12.776.124.790.651.114.224.060.750 cetuximab 185
D12.776.124.790.651.114.224.060.766 daklizumab 6
D12.776.124.790.651.114.224.060.782 denosumab 150
D12.776.124.790.651.114.224.060.790 gemtuzumab 16
D12.776.124.790.651.114.224.060.794 inotuzumab ozogamicin 12
D12.776.124.790.651.114.224.060.798 ipilimumab 253
D12.776.124.790.651.114.224.060.813 natalizumab 156
D12.776.124.790.651.114.224.060.829 nivolumab 432
D12.776.124.790.651.114.224.060.844 omalizumab 112
D12.776.124.790.651.114.224.060.860 palivizumab 12
D12.776.124.790.651.114.224.060.864 panitumumab 57
D12.776.124.790.651.114.224.060.866 ramucirumab 1
D12.776.124.790.651.114.224.060.868 ranibizumab 61
D12.776.124.790.651.114.224.060.875 trastuzumab 269
D12.776.124.790.651.114.224.060.937 ustekinumab 121
D12.776.124.790.651.680 imunoglobuliny - fragmenty 187
D12.776.124.790.651.680.650 imunoglobuliny - Fab fragmenty 65
D12.776.124.790.651.680.650.125 abciximab 14
D12.776.124.790.651.680.650.250 certolizumab pegol 47
D12.776.124.790.651.680.650.500 variabilní oblast imunoglobulinu 36
D12.776.124.790.651.680.650.750 tuftsin 5
D12.776.377 globuliny 68
D12.776.377.715 sérové globuliny 61
D12.776.377.715.548 imunoglobuliny 1 489
D12.776.377.715.548.114 protilátky 1 815
D12.776.377.715.548.114.224 monoklonální protilátky 4 629
D12.776.377.715.548.114.224.200 humanizované monoklonální protilátky 2 790
D12.776.377.715.548.114.224.200.125 abciximab 14
D12.776.377.715.548.114.224.200.250 adalimumab 347
D12.776.377.715.548.114.224.200.375 alemtuzumab 123
D12.776.377.715.548.114.224.200.407 basiliximab 2
D12.776.377.715.548.114.224.200.438 bevacizumab 445
D12.776.377.715.548.114.224.200.469 brentuximab vedotin 40
D12.776.377.715.548.114.224.200.500 certolizumab pegol 47
D12.776.377.715.548.114.224.200.750 cetuximab 185
D12.776.377.715.548.114.224.200.766 daklizumab 6
D12.776.377.715.548.114.224.200.782 denosumab 150
D12.776.377.715.548.114.224.200.790 gemtuzumab 16
D12.776.377.715.548.114.224.200.794 inotuzumab ozogamicin 12
D12.776.377.715.548.114.224.200.798 ipilimumab 253
D12.776.377.715.548.114.224.200.813 natalizumab 156
D12.776.377.715.548.114.224.200.829 nivolumab 432
D12.776.377.715.548.114.224.200.844 omalizumab 112
D12.776.377.715.548.114.224.200.860 palivizumab 12
D12.776.377.715.548.114.224.200.864 panitumumab 57
D12.776.377.715.548.114.224.200.866 ramucirumab 1
D12.776.377.715.548.114.224.200.868 ranibizumab 61
D12.776.377.715.548.114.224.200.875 trastuzumab 269
D12.776.377.715.548.114.224.200.937 ustekinumab 121
D12.776.377.715.548.680 imunoglobuliny - fragmenty 187
D12.776.377.715.548.680.650 imunoglobuliny - Fab fragmenty 65
D12.776.377.715.548.680.650.125 abciximab 14
D12.776.377.715.548.680.650.250 certolizumab pegol 47
D12.776.377.715.548.680.650.500 variabilní oblast imunoglobulinu 36
D12.776.377.715.548.680.650.750 tuftsin 5

Přidat